Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma
出版年份 2021 全文链接
标题
Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma
作者
关键词
-
出版物
Cells
Volume 10, Issue 2, Pages 340
出版商
MDPI AG
发表日期
2021-02-08
DOI
10.3390/cells10020340
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The effects of cannabinoids on glioblastoma growth: A systematic review with meta-analysis of animal model studies
- (2020) Ângelo Luís et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Tumor Cell Invasion in Glioblastoma
- (2020) Arabel Vollmann-Zwerenz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Multispecific drugs herald a new era of biopharmaceutical innovation
- (2020) Raymond J. Deshaies NATURE
- Molecular Targets for Combined Therapeutic Strategies to Limit Glioblastoma Cell Migration and Invasion
- (2020) Andrea J. Yool et al. Frontiers in Pharmacology
- Can Hemp Help? Low-THC Cannabis and Non-THC Cannabinoids for the Treatment of Cancer
- (2020) Farjana Afrin et al. Cancers
- Considering the Experimental Use of Temozolomide in Glioblastoma Research
- (2020) Verena J. Herbener et al. Biomedicines
- 2D and 3D in vitro assays to quantify the invasive behavior of glioblastoma stem cells in response to SDF-1α
- (2020) Vashendriya VV Hira et al. BIOTECHNIQUES
- EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
- (2020) Michael Weller et al. Nature Reviews Clinical Oncology
- Chemotherapy‐induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol
- (2019) Daniel I. Brierley et al. Journal of Cachexia Sarcopenia and Muscle
- Should Oncologists Recommend Cannabis?
- (2019) Donald I. Abrams CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer
- (2019) Ryan C. Gimple et al. GENES & DEVELOPMENT
- Beyond THC and Endocannabinoids
- (2019) Pal Pacher et al. Annual Review of Pharmacology and Toxicology
- Brain malignancies: Glioblastoma and brain metastases
- (2019) Tamara T. Lah et al. SEMINARS IN CANCER BIOLOGY
- Cannabinoids in Glioblastoma Therapy: New Applications for Old Drugs
- (2018) Claudia A. Dumitru et al. Frontiers in Molecular Neuroscience
- Human glioblastoma arises from subventricular zone cells with low-level driver mutations
- (2018) Joo Ho Lee et al. NATURE
- Mitochondrial biogenesis and metabolic hyperactivation limits the application of MTT assay in the estimation of radiation induced growth inhibition
- (2018) Yogesh Rai et al. Scientific Reports
- Evolutionary dynamics of residual disease in human glioblastoma
- (2018) I Spiteri et al. ANNALS OF ONCOLOGY
- Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
- (2017) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cannabidiol: State of the art and new challenges for therapeutic applications
- (2017) Simona Pisanti et al. PHARMACOLOGY & THERAPEUTICS
- Mesenchymal stem cells differentially affect the invasion of distinct glioblastoma cell lines
- (2017) Barbara Breznik et al. Oncotarget
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Regulation of Tumor Progression
- (2016) Christopher J. Coke et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology
- (2016) Alessia Ligresti et al. PHYSIOLOGICAL REVIEWS
- Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration
- (2016) Massimo Nabissi et al. Oncotarget
- Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
- (2016) Daniel A. Ladin et al. Frontiers in Pharmacology
- Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
- (2015) R B Laprairie et al. BRITISH JOURNAL OF PHARMACOLOGY
- Paracrine Effects of Mesenchymal Stem Cells Induce Senescence and Differentiation of Glioblastoma Stem-Like Cells
- (2015) Katja Kološa et al. CELL TRANSPLANTATION
- Cannabis in cancer care
- (2015) DI Abrams et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stem-like cells proliferation by inducing autophagy in a TRPV2-dependent manner
- (2015) Massimo Nabissi et al. INTERNATIONAL JOURNAL OF CANCER
- Complexity of cancer protease biology: Cathepsin K expression and function in cancer progression
- (2015) Urška Verbovšek et al. SEMINARS IN CANCER BIOLOGY
- Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma
- (2015) E Singer et al. Cell Death & Disease
- Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cells
- (2015) Neža Podergajs et al. Oncotarget
- Tetrahydrocannabinol Induces Brain Mitochondrial Respiratory Chain Dysfunction and Increases Oxidative Stress: A Potential Mechanism Involved in Cannabis-Related Stroke
- (2015) Valérie Wolff et al. Biomed Research International
- Roles of TRPM8 Ion Channels in Cancer: Proliferation, Survival, and Invasion
- (2015) Nelson Yee Cancers
- CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide
- (2015) Richard E. Kast et al. Oncotarget
- Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid
- (2014) Francesca Borrelli et al. CARCINOGENESIS
- Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma
- (2013) Krishna P.L. Bhat et al. CANCER CELL
- Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation
- (2013) Ismael Galve-Roperh et al. PROGRESS IN LIPID RESEARCH
- Non-THC cannabinoids inhibit prostate carcinoma growthin vitroandin vivo: pro-apoptotic effects and underlying mechanisms
- (2012) Luciano De Petrocellis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Id-1 Is a Key Transcriptional Regulator of Glioblastoma Aggressiveness and a Novel Therapeutic Target
- (2012) L. Soroceanu et al. CANCER RESEARCH
- Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents
- (2012) Massimo Nabissi et al. CARCINOGENESIS
- Inhibition of cathepsin L lowers the apoptotic threshold of glioblastoma cells by up-regulating p53 and transcription of caspases 3 and 7
- (2011) Saša Kenig et al. APOPTOSIS
- A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma
- (2011) S. Torres et al. MOLECULAR CANCER THERAPEUTICS
- Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive–compulsive behaviour
- (2011) Serena Deiana et al. PSYCHOPHARMACOLOGY
- Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma
- (2010) E. G. Van Meir et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- The leukemic stem cell niche: current concepts and therapeutic opportunities
- (2009) S. W. Lane et al. BLOOD
- Evidence that the plant cannabinoid cannabigerol is a highly potent α2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist
- (2009) MG Cascio et al. BRITISH JOURNAL OF PHARMACOLOGY
- Δ9-Tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells
- (2008) Gil Galanti et al. ACTA ONCOLOGICA
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started